Listen

Brain tumors remain among the most complex and challenging conditions we confront. There are over 120 histologically distinct tumor types, with survival outcomes varying drastically depending on molecular profile and location. As a result, the need for nuanced, multidisciplinary care has never been more evident.

While advances in neuroimaging, genomic profiling, and immunotherapy have shifted paradigms, many patients still face limited treatment options and high morbidity.

During Brain Tumor Awareness Month, we’re reinforcing our shared commitment to early detection, clinical trials, patient-centered research, and the ethical complexities of surgical and systemic interventions. 

From glioblastomas to benign meningiomas, and from pediatric to geriatric cases, we’ll be spotlighting emerging data, revisiting case studies, and discussing how to translate innovation into outcomes.